260 related articles for article (PubMed ID: 36291774)
21. Primary Hepatic Extra-gastrointestinal Stromal Tumors: Molecular Pathogenesis, Immunohistopathology, and Treatment.
Becker EC; Ozcan G; Wu GY
J Clin Transl Hepatol; 2023 Aug; 11(4):942-948. PubMed ID: 37408818
[TBL] [Abstract][Full Text] [Related]
22. Latest advances in adult gastrointestinal stromal tumors.
Florou V; Wilky BA; Trent JC
Future Oncol; 2017 Oct; 13(24):2183-2193. PubMed ID: 28984483
[TBL] [Abstract][Full Text] [Related]
23. Classification of gastrointestinal stromal tumor syndromes.
Gopie P; Mei L; Faber AC; Grossman SR; Smith SC; Boikos SA
Endocr Relat Cancer; 2018 Feb; 25(2):R49-R58. PubMed ID: 29170162
[TBL] [Abstract][Full Text] [Related]
24. Molecular biomarkers for prognosis of gastrointestinal stromal tumor.
Liu X; Chu KM
Clin Transl Oncol; 2019 Feb; 21(2):145-151. PubMed ID: 30003531
[TBL] [Abstract][Full Text] [Related]
25. Approach to wild-type gastrointestinal stromal tumors.
Kays JK; Sohn JD; Kim BJ; Goze K; Koniaris LG
Transl Gastroenterol Hepatol; 2018; 3():92. PubMed ID: 30603728
[TBL] [Abstract][Full Text] [Related]
26. Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib.
Mohammadi M; Gelderblom H
Expert Opin Investig Drugs; 2021 Feb; 30(2):143-152. PubMed ID: 33252274
[No Abstract] [Full Text] [Related]
27. FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.
Shi E; Chmielecki J; Tang CM; Wang K; Heinrich MC; Kang G; Corless CL; Hong D; Fero KE; Murphy JD; Fanta PT; Ali SM; De Siena M; Burgoyne AM; Movva S; Madlensky L; Heestand GM; Trent JC; Kurzrock R; Morosini D; Ross JS; Harismendy O; Sicklick JK
J Transl Med; 2016 Dec; 14(1):339. PubMed ID: 27974047
[TBL] [Abstract][Full Text] [Related]
28. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
29. The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor.
Schaefer IM; DeMatteo RP; Serrano C
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-15. PubMed ID: 35522913
[TBL] [Abstract][Full Text] [Related]
30. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
31. Multifocal gastric gastrointestinal stromal tumors (GISTs) with lymph node metastases in children and young adults: a comparative clinical and histomorphological study of three cases including a new case of Carney triad.
Otto C; Agaimy A; Braun A; Rädecke J; Hoeppner J; Illerhaus G; Werner M; Kontny U; Haller F
Diagn Pathol; 2011 Jun; 6():52. PubMed ID: 21663639
[TBL] [Abstract][Full Text] [Related]
32. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
33. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.
Agaram NP; Wong GC; Guo T; Maki RG; Singer S; Dematteo RP; Besmer P; Antonescu CR
Genes Chromosomes Cancer; 2008 Oct; 47(10):853-9. PubMed ID: 18615679
[TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
Miettinen M; Lasota J
Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
[TBL] [Abstract][Full Text] [Related]
35. Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Neppala P; Banerjee S; Fanta PT; Yerba M; Porras KA; Burgoyne AM; Sicklick JK
Cancer Metastasis Rev; 2019 Sep; 38(3):525-535. PubMed ID: 31773431
[TBL] [Abstract][Full Text] [Related]
36. Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.
Yebra M; Bhargava S; Kumar A; Burgoyne AM; Tang CM; Yoon H; Banerjee S; Aguilera J; Cordes T; Sheth V; Noh S; Ustoy R; Li S; Advani SJ; Corless CL; Heinrich MC; Kurzrock R; Lippman SM; Fanta PT; Harismendy O; Metallo C; Sicklick JK
Clin Cancer Res; 2022 Jan; 28(1):187-200. PubMed ID: 34426440
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in the management of gastrointestinal stromal tumor.
Ahmed M
World J Clin Cases; 2020 Aug; 8(15):3142-3155. PubMed ID: 32874969
[TBL] [Abstract][Full Text] [Related]
38. Molecular research directions in the management of gastrointestinal stromal tumors.
Tarn C; Godwin AK
Curr Treat Options Oncol; 2005 Nov; 6(6):473-86. PubMed ID: 16242052
[TBL] [Abstract][Full Text] [Related]
39. Current Molecular Profile of Gastrointestinal Stromal Tumors and Systemic Therapeutic Implications.
Mathias-Machado MC; de Jesus VHF; de Carvalho Oliveira LJ; Neumann M; Peixoto RD
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358751
[TBL] [Abstract][Full Text] [Related]
40. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
Miettinen M; Majidi M; Lasota J
Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
